Please ensure Javascript is enabled for purposes of website accessibility
Moderna Asking Regulators to OK Its Virus Shots
gvw_ap_news
By Associated Press
Published 4 years ago on
November 30, 2020

Share

Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.

Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago in China, the virus has killed more than 1.4 million people worldwide.

Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. British regulators also are assessing the Pfizer shot and another from AstraZeneca.

Moderna created its shots with the U.S. National Institutes of Health and already had a hint they were working, but said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.

Of 196 COVID-19 cases so far in its huge U.S. study, 185 were trial participants who received the placebo and 11 who got the real vaccine. The only people who got severely ill — 30 participants, including one who died — had received dummy shots, said Dr. Tal Zaks, the Cambridge, Massachusetts, company’s chief medical officer.

When he learned the results, “I allowed myself to cry for the first time,” Zaks told The Associated Press. “We have already, just in the trial, have already saved lives. Just imagine the impact then multiplied to the people who can get this vaccine.”

Moderna said the shots’ effectiveness and a good safety record so far — with only temporary, flu-like side effects — mean they meet requirements set by the U.S. Food and Drug Administration for emergency use before the final-stage testing is complete. The European Medicines Agency, Europe’s version of FDA, has signaled it also is open to faster “conditional” clearance.

What Comes Next

The FDA has pledged that before it decides to roll out any COVID-19 vaccines, its scientific advisers will publicly debate whether there’s enough evidence behind each candidate.

First up on Dec. 10, Pfizer and BioNTech will present data suggesting their vaccine candidate is 95% effective. Moderna said its turn at this “science court” is expected exactly a week later, on Dec. 17.

Rationing Initial Doses

If the FDA allows emergency use, Moderna expects to have 20 million doses ready for the U.S. by year’s end. Recipients will need two doses, so that’s enough for 10 million people.

Pfizer expects to have 50 million doses globally in December. Half of them — or enough for 12.5 million people — are earmarked for the U.S.

Shipments are set to begin to states within 24 hours of FDA clearance. And this week, a different panel of U.S. experts, established by the Centers for Disease Control and Prevention, will meet to decide how those initial supplies will be given out. They’re expected to reserve scarce first doses for health care workers and, if the shots work well enough in the frail elderly, for residents of long-term care facilities.

As more vaccine gradually becomes available in coming months, other essential workers and people at highest risk from the coronavirus would get in line. But enough for the general U.S. population isn’t expected until at least spring.

Outside the U.S., Zaks said significant supplies from Moderna would be available later, “in the first quarter” of next year.

“Obviously we are doing everything in our power to increase the capacity and accelerate the timelines,” he said.

Britain’s government said Sunday it has ordered 7 million doses from Moderna.

The U.K. also has ordered 40 million doses of the Pfizer-BioNTech vaccine, although it’s not clear how much of the companies’ limited December supply could go toward that order — if British health authorities clear the shots. Still, British hospitals are gearing up to receive some doses as early as next week.

Both Moderna’s and Pfizer’s vaccines are made with the same technology, using a piece of genetic code for the “spike” protein that studs the virus. That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

AstraZeneca Confusion

AstraZeneca and Oxford University last week announced confusing early results of their vaccine candidate from research in Britain and Brazil.

That vaccine appears 62% effective when tested as originally intended, with recipients given two full doses. But because of a manufacturing error, a small number of volunteers got a lower first dose — and AstraZeneca said in that group, the vaccine appeared to be 90% effective.

Experts say it’s unclear why the lower-dose approach would work better and that it may just be a statistical quirk.

A larger U.S. study of the AstraZeneca candidate still is underway that should eventually give the FDA a better picture of how well it works. The FDA has said any COVID-19 vaccine would have to be at least 50% effective.

Meanwhile Britain’s government will have to decide whether its U.K. data is sufficient for an early rollout there.

Still in the Pipeline

Johnson & Johnson also is in final-stage testing in the U.S. and several other countries to see if its vaccine candidate could work with just one dose.

Both the J&J and AstraZeneca vaccines work by using harmless cold viruses to carry the spike protein gene into the body and prime the immune system.

The different technologies have ramifications for how easily different vaccines could be distributed globally. The AstraZeneca shots won’t require freezer storage like the Pfizer and Moderna vaccines.

Candidates made with still other technologies are in late-stage testing, too. Another U.S. company, Novavax Inc., announced Monday that it has finished enrolling 15,000 people in a late-stage study in Britain and plans to begin recruiting even more volunteers for final testing in the U.S. and Mexico “in the coming weeks.”

Vaccines made by three Chinese companies and a Russian candidate also are being tested in thousands of people in countries around the world.

RELATED TOPICS:

DON'T MISS

‘Leave It the Way It Is’: Off-Roaders, Hikers React to Proposal to Change 1.4M Acres of Sierra Forest

DON'T MISS

Yankees Retain Cole, Add $36 Million Extension to Keep Ace

DON'T MISS

5 Reasons Early Voting Is Overwhelmed With Falsehoods

DON'T MISS

Christian McCaffrey Returns to Practice for the 49ers From Achilles Tendon Injury

DON'T MISS

California Sues LA Suburb for Temporary Ban of Homeless Shelters

DON'T MISS

You May Have Blocked Someone on X but Now They Can See Your Public Posts Anyway

DON'T MISS

Some Republican-Led States Refuse to Let Justice Department Monitors Into Polling Places

DON'T MISS

Fresno Police Arrest Suspect in Fatal NW Apartment Shooting

DON'T MISS

Fresno Murder Suspect Stopped in Las Vegas, Others Wanted

DON'T MISS

Trump’s Crowds Are Dwindling as His Campaign Winds Down

UP NEXT

North Korea’s Long-Range Missile Test Signals Its Improved, Potential Capability to Attack US

UP NEXT

Visalia Rollerblader Suffered Major Injuries After Being Struck by Vehicle

UP NEXT

Fresno County Man Indicted for Possessing Stolen Guns

UP NEXT

On Elon Musk’s X, Dems Are an Endangered Species While GOP Goes Viral

UP NEXT

New Vehicles, Face Paint and a 1,200-Foot Fall: The US Army Prepares for War With China

UP NEXT

CNN Bars Pro-Trump Guest After His ‘Beeper’ Remark to Mehdi Hasan

UP NEXT

LGBTQ Supporters Drown Out Westboro Baptists’ Anti-Gay Message in Fresno

UP NEXT

The ‘Black Insurrectionist’ Was Actually White. The Deception Did Not Stop There

UP NEXT

Washington Post Says It Will Stop Endorsing Presidential Candidates

UP NEXT

What Happened When a Barber Told Trump About His $15,000 Electric Bill

Christian McCaffrey Returns to Practice for the 49ers From Achilles Tendon Injury

2 hours ago

California Sues LA Suburb for Temporary Ban of Homeless Shelters

2 hours ago

You May Have Blocked Someone on X but Now They Can See Your Public Posts Anyway

3 hours ago

Some Republican-Led States Refuse to Let Justice Department Monitors Into Polling Places

3 hours ago

Fresno Police Arrest Suspect in Fatal NW Apartment Shooting

3 hours ago

Fresno Murder Suspect Stopped in Las Vegas, Others Wanted

3 hours ago

Trump’s Crowds Are Dwindling as His Campaign Winds Down

4 hours ago

Trump Threatens 25% Tariff on Mexico to Curb Immigration

4 hours ago

Music Legend Quincy Jones, Architect of Pop’s Greatest Hits, Dies at 91

4 hours ago

Big Pharma Backs Harris 6-to-1 Over Trump in Presidential Campaign Contributions

5 hours ago

‘Leave It the Way It Is’: Off-Roaders, Hikers React to Proposal to Change 1.4M Acres of Sierra Forest

The 1.4 million acres of Sierra National Forest land proposed for a national monument would make the land between Yosemite and Sequoia natio...

6 mins ago

6 mins ago

‘Leave It the Way It Is’: Off-Roaders, Hikers React to Proposal to Change 1.4M Acres of Sierra Forest

New York Yankees pitcher Gerrit Cole throws against the Los Angeles Dodgers during the first inning in Game 5 of the baseball World Series, Wednesday, Oct. 30, 2024, in New York. (AP/Ashley Landis)
2 hours ago

Yankees Retain Cole, Add $36 Million Extension to Keep Ace

Voters cast their ballots at Desert Breeze Community Center in Las Vegas during the last day of in-person early voting in Nevada on Friday, Nov. 1, 2024. Nearly 75 million people have cast early ballots, making their voices heard amid worry about the process, the outcome and democracy itself. (Bridget Bennett/The New York Times)
2 hours ago

5 Reasons Early Voting Is Overwhelmed With Falsehoods

2 hours ago

Christian McCaffrey Returns to Practice for the 49ers From Achilles Tendon Injury

2 hours ago

California Sues LA Suburb for Temporary Ban of Homeless Shelters

3 hours ago

You May Have Blocked Someone on X but Now They Can See Your Public Posts Anyway

3 hours ago

Some Republican-Led States Refuse to Let Justice Department Monitors Into Polling Places

Gerrick Franklin (pictured), 34, was taken into custody Sunday in Madera County on suspicion of killing Tyler Hamon, 33. (Fresno PD)
3 hours ago

Fresno Police Arrest Suspect in Fatal NW Apartment Shooting

Search

Send this to a friend